Back to search

Article

Cost-Utility and Cost-Effectiveness Analysis of disease-modifying drugs of Relapsing-Remitting Multiple Sclerosis: A Systematic Review

2022-08-12

Abstract excerpt

<h4>Background</h4> Multiple sclerosis is a chronic demyelinating disorder of the central nervous system that is categorized as an immune-mediated inflammatory disease. This study aimed to systematically review the cost-benefit and cost-effectiveness of relapsing-remitting drugs for multiple sclerosis. <h4>Methods</h4> To find related research and articles, articles published in Iranian and international databases...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
956dd18f-ddb1-5358-9cb9-389724b51d58
DOI
10.1101/2022.08.10.22278518
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cost-Utility and Cost-Effectiveness Analysis of disease-modifying drugs of Relapsing-Remitting Multiple Sclerosis: A Systematic ReviewDOI 10.1101/2022.08.10.22278518
Select a neighboring publication to make it the new centre.